Norlase is an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease. Norlase is comprised of worldwide industry leaders and experts in ophthalmology, laser technology, medical device development and customer care.
Norlase is on a mission to improve the lives of ophthalmologists and patients around the world. Norlase unique heritage in laser technology allows to approach challenges in ophthalmology through a new lens - developing solutions that provide superior use and practice value in the doctor’s clinic.
Therefore Norlase is developing next-generation lasers that allows Ophthalmologist to treat more patients, maximize practice space, and provide the quality of care and increased safety that your patients are seeking.